Skip Navigation LinksHome > October 2012 - Volume 50 - Issue 10 > Using Electronic Health Care Records for Drug Safety Signal...
Medical Care:
doi: 10.1097/MLR.0b013e31825f63bf
Original Articles

Using Electronic Health Care Records for Drug Safety Signal Detection: A Comparative Evaluation of Statistical Methods

Schuemie, Martijn J. PhD*; Coloma, Preciosa M. MD, MS*; Straatman, Huub MS; Herings, Ron M. C. PhD*,†; Trifirò, Gianluca MD, PhD*,‡; Matthews, Justin Neil MS§; Prieto-Merino, David PhD§; Molokhia, Mariam PhD; Pedersen, Lars PhD; Gini, Rosa PhD#; Innocenti, Francesco MS#,**; Mazzaglia, Giampiero MD, PhD**; Picelli, Gino††; Scotti, Lorenza MS‡‡; van der Lei, Johan MD, PhD*; Sturkenboom, Miriam C. J. M. PhD*

Supplemental Author Material
Collapse Box

Abstract

Background: Drug safety monitoring relies primarily on spontaneous reporting, but electronic health care record databases offer a possible alternative for the detection of adverse drug reactions (ADRs).

Objectives: To evaluate the relative performance of different statistical methods for detecting drug-adverse event associations in electronic health care record data representing potential ADRs.

Research Design: Data from 7 databases across 3 countries in Europe comprising over 20 million subjects were used to compute the relative risk estimates for drug-event pairs using 10 different methods, including those developed for spontaneous reporting systems, cohort methods such as the longitudinal gamma poisson shrinker, and case-based methods such as case-control. The newly developed method “longitudinal evaluation of observational profiles of adverse events related to drugs” (LEOPARD) was used to remove associations likely caused by protopathic bias. Data from the different databases were combined by pooling of data, and by meta-analysis for random effects. A reference standard of known ADRs and negative controls was created to evaluate the performance of the method.

Measures: The area under the curve of the receiver operator characteristic curve was calculated for each method, both with and without LEOPARD filtering.

Results: The highest area under the curve (0.83) was achieved by the combination of either longitudinal gamma poisson shrinker or case-control with LEOPARD filtering, but the performance between methods differed little. LEOPARD increased the overall performance, but flagged several known ADRs as caused by protopathic bias.

Conclusions: Combinations of methods demonstrate good performance in distinguishing known ADRs from negative controls, and we assume that these could also be used to detect new drug safety signals.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.